Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.
Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity.
Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice.
Dr. Boccia compares CancerTYPE ID to other gene expression tests and reviews studies validating its accuracy and clinical utility.
Matthew Palmgren discusses impact on positive collaboration between the payer and physician
Matthew Palmgren presents the importance of collaboration between the payer and physician for better medication adherence
Dr. Edward Garon provides an overview of the most common presenting clinical features in adults with non-small cell lung cancer (NSCLC).
John Hennessy discusses the "affordabilty index" of curing cancer
Gary Owens discusses the complexities of cost-sharing as it relates to cancer care. He cites the fact that the cost of cancer care has increased dramatically and benefit designs have decreased, disproportionately affecting cancer patients. He also talks about AVBCC's role in moving the discussion toward solving the issues surrounding the cost of cancer treatment.
Page 3 of 9
Results 21 - 30 of 89
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME